Key risks
Chronic unprofitability eroded equity: 7 of 8 recent quarters were loss-making (losses ranged from ₹3.72 to ₹11.18 Cr), resulting in a negative ROE of -15.73%
Revenue severely unstable: Quarterly sales ranged from ₹0.72 Cr (Jun 2024) to ₹48.76 Cr (Dec 2024); verify if recent stabilization at ₹39.14 Cr (Mar 2025) is structural or cyclical
No institutional confidence: FII and DII holdings at 0%; verify whether regulatory barriers or discretionary underweight drive this absence
Margin collapse history: Operating margins ranged from +6.72% to -484.09% across quarters; verify costing discipline and cost-structure sustainability
Generated analysis · source review pending